In The Battle Against COVID-19, A Risk Of ‘Vaccine Nationalism’

The race to defeat the coronavirus is generating competition among nations and multinational companies that’s being described as “vaccine nationalism.”

(Image credit: Kevin Lamarque/Reuters)